Douglas Carr sold $3,050 of IPSC
SVP Finance & Operations at Century Therapeutics, Inc.. 4,904 shares at an average of $0.62, traded Jun 9, 2025, filed Jun 11, 2025.
Score components
- +15RoleOfficer
- 0Trade size$3k at market
- 0Share of holdings soldSold 1.2% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-011429, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 9, 2025 | SOpen-market sale Common Stock | -4,904 | $0.62 | $3,050 | 405,982 | Jun 11, 2025 |
Related signals
Other insiders at Century Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $3,200 1,658 shares | -0% | |
| 23Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $4,993 2,587 shares | -1% | |
| 23Weak | Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $521 254 shares | -0% | |
| 23Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $1,095 534 shares | -0% | |
| 30Weak | Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $132 263 shares | -0% | |
| 30Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $270 539 shares | -0% | |
| 40Moderate | Century Therapeutics, Inc. | Brent Pfeiffenberger President and CEO | $244 488 shares | -0% | |
| 15Weak | IPSCsell Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $158 296 shares | -0% | |
| 30Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $327 526 shares | -0% | |
| 40Moderate | Century Therapeutics, Inc. | Brent Pfeiffenberger President and CEO | $295 475 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.